DLK1(PREF1) is a negative regulator of adipogenesis in CD105+/CD90+/CD34+/CD31- /FABP4- adipose-derived stromal cells from subcutaneous abdominal fat pats of adult women
Fiche du document
17 juillet 2012
- handle: 10670/1.03616c
- issn: 1873-5061
- doi: 10.1016/j.scr.2012.04.001
info:eu-repo/semantics/openAccess
Sujets proches
Adipose cells Adipocytes Womyn Wimmin Woman Womon Human females Fats Expressive behavior Women's workCiter ce document
Andreas Kaiser et al., « DLK1(PREF1) is a negative regulator of adipogenesis in CD105+/CD90+/CD34+/CD31- /FABP4- adipose-derived stromal cells from subcutaneous abdominal fat pats of adult women », Elektronisches Publikationsportal der Österreichischen Akademie der Wissenschafte, ID : 10.1016/j.scr.2012.04.001
Métriques
Partage / Export
Résumé
The main physiological function of adipose-derived stromal/progenitor cells (ASC) is to differentiate into adipocytes. ASC are most likely localized at perivascular sites in adipose tissues and retain the capacity to differentiate into multiple cell types. Although cell surface markers for ASC have been described, there is no complete consensus on the antigen expression pattern that will precisely define these cells. DLK1(PREF1) is an established marker for mouse adipocyte progenitors which inhibits adipogenesis. This suggests that DLK1(PREF1) could be a useful marker to characterize human ASC. The DLK1(PREF1) status of human ASC is however unknown. In the present study we isolated ASC from the heterogeneous stromal vascular fraction of subcutaneous abdominal fat pats of adult women. These cells were selected by their plastic adherence and expanded to passage 5. The ASC were characterized as relatively homogenous cell population with the capacity to differentiate in vitro into adipocytes, chondrocytes, and osteoblasts and the immunophenotype CD105+/CD90+/CD34+/CD31-/FABP4-. The ASC were positive for DLK1(PREF1) which was well expressed in proliferating and density arrested cells but downregulated in the course of adipogenic differentiation. To investigate whether DLK1(PREF1) plays a role in the regulation of adipogenesis in these cells RNAi-mediated knockdown experiments were conducted. Knockdown of DLK1(PREF1) in differentiating ASC resulted in a significant increase of the expression of the adipogenic key regulator PPARγ2 and of the terminal adipogenic differentiation marker FABP4. We conclude that DLK1(PREF1) is well expressed in human ASC and acts as a negative regulator of adipogenesis. Moreover, DLK1(PREF1) could be a useful marker contributing to the characterization of human ASC.